SEPT5-GP1BB: A Potential Drug Target and Biomarker (G100526833)

Target Name: SEPT5-GP1BB

NCBI ID: G100526833

SEPT5-GP1BB

SEPT5-GP1BB: A Potential Drug Target and Biomarker

SEPT5-GP1BB is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a key regulator of the cell cycle and has been implicated in a number of cellular processes. In recent years, researchers have discovered that SEPT5-GP1BB is also a potential drug target and biomarker.

The cell cycle is the process by which cells grow, divide, and replicate their genetic material. The cell cycle is regulated by a complex network of proteins, includingSEPT5-GP1BB. This protein plays a critical role in controlling the rate at which cells divide and in preventing cell proliferation.

SEPT5-GP1BB is a transcription factor that is involved in the regulation of gene expression. It is composed of two distinct domains: a N-terminal domain that contains a protein-coding region and a C-terminal domain that contains a zinc finger transcription factor-like domain. The N-terminal domain is responsible for binding to DNA and the C-terminal domain is responsible for interacting with other proteins.

SEPT5-GP1BB has been shown to play a role in the regulation of cellular processes that are important for human health. For example, studies have shown that SEPT5-GP1BB is involved in the regulation of cell proliferation, differentiation, and apoptosis. It has also been shown to play a role in the development and progression of a number of diseases, including cancer.

In addition to its role in cellular processes, SEPT5-GP1BB has also been shown to be a potential drug target. Researchers have identified several potential drug candidates that are designed to interact with SEPT5-GP1BB and inhibit its activity. These drugs have the potential to treat a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

SEPT5-GP1BB is also a potential biomarker for a number of diseases. Its expression has been shown to be elevated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that SEPT5-GP1BB may be a useful biomarker for these diseases and could potentially serve as a target for diagnostic tests.

In conclusion, SEPT5-GP1BB is a protein that is involved in the regulation of the cell cycle and has been implicated in a number of cellular processes. In recent years, researchers have discovered that SEPT5-GP1BB is also a potential drug target and biomarker. Its properties and functions continue to be an active area of research, and its potential as a drug target and biomarker should be further explored.

Protein Name: SEPT5-GP1BB Readthrough

The "SEPT5-GP1BB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEPT5-GP1BB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets